CRANBURY, N.J.--(BUSINESS WIRE)--NeurologyLive™, a digital and print multimedia platform dedicated to providing health care professionals treating neurological diseases direct access to expert, practice-changing news and insights in neurology, presents its most recent “Peer Exchange” panel discussion, “Epilepsy: Current Trends and Treatments for Focal Seizures.” The video series welcomes several experts in the treatment and management of epilepsy who provide peer-to-peer dialogue, authoritative insights, opinions and perspectives on current trends and available treatments for focal seizures.
“Approximately 3 million people in the United States are diagnosed with epilepsy,” said Michael J. Hennessy Jr., president of MJH Associates, Inc., parent company of NeurologyLive™. “In this discussion, our panel of experts will discuss the use of new and exciting therapeutic options and will provide a practical perspective on how the recent data applies to their clinical practice.”
This NeurologyLive™ “Peer Exchange” panel features four distinguished experts: Michael R. Sperling, M.D., Baldwin Keyes professor of neurology, director of the Jefferson Comprehensive Epilepsy Center and Clinical Neurophysiology Laboratory at Thomas Jefferson University, as the moderator; Kathryn A. Davis, M.D., M.S, FAES, assistant professor of neurology at the Hospital of the University of Pennsylvania and medical director of the Epilepsy Monitoring Unit and Epilepsy Surgical Program at the University of Pennsylvania; Trevor J. Resnick, M.D., pediatric neurologist in the department of neurology at Nicklaus Children’s Hospital-Brain Institute of the Miami Children’s Health System and a clinical professor in the department of neurology at Herbert Wertheim College of Medicine; and Jesus E. Pina-Garza, M.D., director of pediatric epilepsy at TriStar Medical Group Children’s Specialists.
The first segment of this “Peer Exchange” series provides an overview of epilepsy and the current understanding of it, as well as an in-depth discussion about the pharmacologic treatments for focal seizures. Panelists also explore current processes and tools involved in the accurate diagnosis and evaluation of epilepsy, as well as how far physicians should go in making a diagnosis. In addition, the panel discusses the goals of initiating therapy and the current state of diagnostic and prognostic biomarkers and how they can be useful for physicians.
For more information and to view the video series on NeurologyLive.com, click here. The series can also be viewed on MDMag.com.
About NeurologyLive™
A digital and print multimedia platform for health care professionals treating neurological diseases, NeurologyLive™ delivers direct access to practice-changing news and expert insight directly from top medical conferences and researchers to improve the lives of patients with neurological diseases such as dementia and Alzheimer disease, epilepsy, headache and migraine, movement disorders, multiple sclerosis, neuromuscular diseases, sleep medicine and stroke. The NeurologyLive™ platform offers an in-depth look at hundreds of new treatments in development with ever-expanding mechanisms of action, all during an unprecedented time of growing demand for neurology expertise. The NeurologyLive™ platform also connects visitors with the most up-to-date clinical trial results, Food and Drug Administration approvals, practice-changing research and expert insight. NeurologyLive™ is part of the Cranbury, New Jersey-based MJH Associates, Inc., health care enterprise, which includes OncLive® and CURE® magazine. For more information, visit http://www.mjhassoc.com.
